Morgan Stanley maintains Brown & Brown at Underweight, raises price target to $60 from $55

Morgan Stanley kept its Underweight rating on Brown & Brown but raised its price target to $60 from $55, citing a 16.6% downside from the Nov 13 close. Other recent analyst targets range from $72 to $85.

Original reporting
Published Nov 16, 2026, 3:01 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 16, 2026, 3:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Morgan Stanley maintains Brown & Brown at Underweight, raises price target to $60 from $55 — source image
Decision brief

The 30-second read

$BROBearishLow
01

Why it matters

The rating remains Underweight with a modest target increase, implying limited upside and possible downside pressure.

02

Market read

A new analyst rating and target adjustment for BRO may influence short‑term trading sentiment but is unlikely to drive major market moves.

03

What to watch

Potential upcoming earnings or market conditions could alter the impact of the rating.

Relevance 5/10Novelty 5/10Timing: today

Background

Morgan Stanley's analyst note updates the price target and rating for Brown & Brown, a publicly traded insurance firm.

Company-level read

Ticker impact

$BROBearishMedium confidence
Context

Morgan Stanley maintained an Underweight rating on Brown & Brown and raised its price target to $60 from $55.

Expected impact

likely pressure as the market prices in the Underweight stance and modest target increase

Evidence & confidence

The new target is still below current price, and the Underweight rating signals limited upside.

Market effects

Minimal impact on the insurance sector; rating change is isolated to Brown & Brown.

No broader regional effect.

Limited to investors tracking broker analyst updates.

Counterpoint

The target raise could be seen as a bullish signal if the stock rebounds above $60.

Key entities

  • Brown & Brown

    Insurance brokerage firm (NYSE: BRO).

  • Morgan Stanley

    Equity research analyst firm issuing the rating.

Related articles

$BROHighAI 8/10

Why Brown & Brown Stock Slumped by 5% Today

Brown & Brown (BRO) stock fell 5% after Q3 earnings missed estimates. Revenue rose 7% YoY to $1.73B, below the $1.76B consensus. GAAP net income increased 6% to $240M, while adjusted EPS grew 2% to $1.07, missing the $1.09 estimate. The company cited a challenging rate environment and attributed some growth to its Accession acquisition, but organic revenue grew only 1% YoY to $1.46B.

$BROMed

Brown & Brown Inc (BRO) (Q3 2026) Earnings Call Highlights: Revenue Up 7.4%

Brown & Brown Inc (BRO) reported Q3 2026 revenue up 7.4% to $1.07B, but adjusted EBITDAC margin fell 200 bps to 34.6%. Specialty Distribution organic revenue declined 0.8%, missing expectations due to competition and pricing pressures. The company anticipates further declines in Q4 and faces ongoing litigation impacts. Integration costs for Accession have increased to $250-300M.

$BROMed

What Brown & Brown (BRO) Said on Its Q3 Earnings Call

Brown & Brown (BRO) reported Q3 earnings, noting market shifts in California and Texas, and pricing pressures in commercial earthquake business. The company expects 2027 growth of 2%-4% for retail and 1%-3% for specialty distribution. Accession acquisition raised synergy targets to $50M for 2026 and $175M by 2028. AI initiatives are expanding across the company, with tools like Claude and COMPASS being deployed. The board increased the dividend by 9%.